Caldwell Trust’s Sanofi Contingent Value Rights GCVRZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-42
Closed -$36 831
2019
Q4
$36 Buy
+42
New +$32 ﹤0.01% 800

Caldwell Trust's GCVRZ Position: Q1 2020 in Review

Caldwell Trust sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 42 shares — an estimated $36 sold.

Caldwell Trust first reported a position in GCVRZ in Q4 2019 and held it in 1 quarter. The position peaked at $36 in Q4 2019. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.

  • Caldwell Trust reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
  • Caldwell Trust sold 42 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $36.
  • Caldwell Trust first reported a position in Sanofi Contingent Value Rights in Q4 2019 and held it in 1 quarter.
  • Caldwell Trust's Sanofi Contingent Value Rights position peaked at $36 in Q4 2019.
  • 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.

Based on Caldwell Trust's 13F filing for Q1 2020, filed 2 Oct 2025.